Table 2.
Existing priorities now requiring greater research emphasis and new priorities not in the WHO roadmap or AAS list (all data from participants working in less-resourced countries apart from those priorities asterisked which originated from participants working in higher income countries)
Existing priorities now requiring greater research emphasis | |
Infection recurrence | |
Understanding infections and outcomes in vulnerable populations including children, persons living with disabilities, ethnic groups | |
Relationship between repeated viral exposure and disease severity (in frontline workers)** | |
The effects of the disease on pregnant women | |
Effective use of PPE for frontline healthcare workers (emphasis on nurses) | |
Health systems research and strengthening to mitigate impact of COVID-19 on capacity | |
Understanding zoonotic leap between human and animals | |
The impact of redirecting resources and public health interventions towards COVID-19 on other disease burdens | |
Adherence to and trust in public health interventions such as quarantine and social distancing | |
Evaluation of public health interventions in varied settings | |
Public health messaging and addressing myths and mistrust | |
Engaging relevant stakeholders (including religious leaders) in research to enhance community sensitisation, adherence to public health measures, detection and surveillance | |
Effective and feasible ways of community engagement during lockdowns and social distancing. | |
New priorities | |
Virus natural history, transmission and diagnostics | Improved diagnostic tools for safer sample collection, faster and easier assays |
Epidemiological studies | Examine relationships to other lung diseases. The impact of improved WASH practices on WASH-related infections diseases. Long-term health impacts and complications of contracting COVID-19—with emphasis on children/those with comorbidities. |
Clinical management | Clinical guidelines for post-hospitalisation home management and community rehabilitation. Palliative care for COVID-19 patients. Vitamin D levels in COVID-19 severity.** |
Candidate therapeutics R&D | Investigate the potential role of natural/traditional remedies. What would the target therapeutic be with our new knowledge. Evaluate therapeutics in the community in early infection. |
Candidate vaccines R&D | Innovative vaccine delivery modalities |
Ethical considerations for research | Ethical considerations for resource allocation to LMICs. Ethical considerations of recruiting final year medical/nursing students. |
Social sciences in the outbreak response | Understanding COVID-19 in the contexts of conflict, civil war and refugee situations. Examine the effects of the pandemic on the participation of the public in democratic processes. |
Infection prevention and control | How to ensure effective social distancing in public spaces and congregate settings post lockdown** |
The environmental impact of the response to COVID-19 | Determine the impact of: Public Health Interventions on the environment (including air pollution and carbon dioxide emissions)
|
Preparing for the next pandemic | Ensure effective measures including community surveillance and animal screening techniques are in place to rapidly identify emerging zoonotic diseases. Evaluation of governmental policies and lessons learnt in preparation for the next pandemic. |
Cross-cutting | The use of technology in various aspects of pandemic response. Assess effective ways of conducting cross-disciplinary research. |
All data from low-income countries apart from the three priorities marked as ** which are only from participants from high-income countries.
LMICs, low-and-middle-income countries; PPE, personal protective equipment.